中国普外基础与临床杂志

中国普外基础与临床杂志

FGFR2 基因 rs2981582 位点多态性与中国人群乳腺癌易感性关系的 meta 分析

查看全文

目的 评价 FGFR2 基因 rs2981582 位点多态性与中国人群乳腺癌易感性的相关性。 方法 计算机检索 PubMed、Embase、Cochrane Library、中文科技期刊全文数据库、中国生物医学文献数据库、中国期刊全文数据库及万方数据库,检索有关 FGFR2 基因 rs2981582 位点的多态性与中国人群乳腺癌易感性关系的病例对照研究,检索时间为建库到 2018 年 3 月。采用 Stata 12.0 软件进行 meta 分析。 结果 共纳入 11 篇病例对照研究进行 meta 分析,其中病例组包括 5 921 例乳腺癌患者,对照组包括 5 909 位健康对照。meta 分析结果显示,对于中国人群而言,等位基因模型 [C 比 T:OR=1.07,95% CI 为(1.01,1.14),P=0.027]、杂合子模型 [CC 比 CT:OR=1.12,95% CI 为(1.01,1.24),P=0.026]、纯合子模型 [CC 比 TT:OR=1.19,95% CI 为(1.05,1.34),P=0.005]、显性模型 [CC 比 CT+TT:OR=1.10,95% CI 为(1.00,1.21),P=0.040] 及隐性模型 [TT 比 CC+CT:OR=1.19,95% CI 为(1.10,1.30),P<0.001]均与乳腺癌有关。 结论 FGFR2 基因 rs2981582 位点的多态性与中国人群乳腺癌的发生相关。

Objective To evaluate the association between fibroblast growth factor receptor 2 (FGFR2) rs2981582 polymorphism and the risk of breast cancer in Chinese population. Methods PubMed, Embase, Cochrane Library, Chinese Science and Technology Academic Journal, Chinese Biomedical Literature Database, Chinese Journal Full-Text Database, and Wanfang Database were searched to identify relevant articles that investigated the association of FGFR2 rs2981582 polymorphism with breast cancer risk from their inception to March 2018. A meta-analysis was performed by using the Stata 12.0 software. Results A total of 11 case-control studies were included in the present meta-analysis, including 5 921 breast cancer cases and 5 909 healthy controls. The pooled results indicated that, there was significant association between FGFR2 rs2981582 polymorphism and susceptibility of breast cancer in Chinese population under allele model [C vs. T: OR=1.07, 95% CI was (1.01, 1.14), P=0.027], heterozygote model [CC vs. CT: OR=1.12, 95% CI was (1.01, 1.24), P=0.026], homozygous model [CC vs. TT: OR=1.19, 95% CI was (1.05, 1.34), P=0.005], dominant model [CC vs. CT+TT: OR=1.10, 95% CI was (1.00, 1.21), P=0.040], and recessive model [TT vs. CC+CT: OR=1.19, 95% CI was (1.10, 1.30), P<0.001]. Conclusion FGFR2 rs2981582 polymorphism was associated with the risk of breast cancer in Chinese population.

关键词: 乳腺癌; 成纤维细胞生长因子受体 2; rs2981582 位点多态性; meta 分析

Key words: breast cancer; fibroblast growth factor receptor 2; rs2981582 polymorphism; meta-analysis

引用本文: 张之涛, 杨仲俊, 王晓琼, 闫鹏. FGFR2 基因 rs2981582 位点多态性与中国人群乳腺癌易感性关系的 meta 分析. 中国普外基础与临床杂志, 2018, 25(10): 1227-1235. doi: 10.7507/1007-9424.201806048 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
2. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet, 2007, 39(7): 870-874.
3. Brooks AN, Kilgour E, Smith PD. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer. Clin Cancer Res, 2012, 18(7): 1855-1862.
4. Tannheimer SL, Rehemtulla A, Ethier SP. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res, 2000, 2(4): 311-320.
5. Cui F, Wu D, Wang W, et al. Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis. Breast Cancer Res Treat, 2016, 155(2): 313-335.
6. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
7. Liang J, Chen P, Hu Z, et al. Genetic variants in fibroblast growth factor receptor 2(FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis, 2008, 29(12): 2341-2346.
8. 赵洪猛, 张斌, 姚慧, 等. FGFR2 基因多态性与乳腺癌易感性的相关性研究. 中国肿瘤临床, 2010, 37(11): 626-629.
9. 张敬平, 钱云, 王福如, 等. 成纤维细胞生长因子受体 2(FGFR2)多态性与乳腺癌易感性的关联研究. 中华疾病控制杂志, 2010, 14(8): 764-767.
10. 胡飞飞, 周菁, 庞柯, 等. 湖北地区人群乳腺癌易感基因 FGFR2 多态性研究. 中华肿瘤防治杂志, 2011, 18(2): 89-91.
11. Chen F, Lu M, Xue Y, et al. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. Immunogenetics, 2012, 64(1): 71-76.
12. Fu F, Wang C, Huang M, et al. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. Tohoku J Exp Med, 2012, 226(3): 221-229.
13. Chan M, Ji SM, Liaw CS, et al. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. Breast Cancer Res Treat, 2012, 136(1): 209-220.
14. Liu CL, Hu XP, Guo WD, et al. Case-control study on the fibroblast growth factor receptor 2 gene polymorphisms associated with breast cancer in Chinese han women. J Breast Cancer, 2013, 16(4): 366-371.
15. 潘琳, 胡小平, 郭卫东, 等. FGFR2 基因 rs2981582 和 rs1219648 与乳腺癌相关性研究. 宁夏医科大学学报, 2014, 36(8): 853-856.
16. Xi J, Su Y, Beeghly Fadiel A, et al. Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk. Cancer Epidemiol, 2014, 38(6): 708-714.
17. 沈国双, 郑方超, 曹成珠, 等. 青海地区藏族 FGFR2 基因多态性与乳腺癌的相关性研究. 重庆医学, 2016, 45(16): 2209-2211.
18. Siddiqui S, Chattopadhyay S, Akhtar MS, et al. A study on genetic variants of fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India. PLoS One, 2014, 9(10): e110426.
19. Katoh Y, Katoh M. FGFR2-related pathogenesis and FGFR2-targeted therapeutics (review). Int J Mol Med, 2009, 23(3): 307-311.
20. Yang YB, Zhao ZX, Huang W, et al. Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: a HuGE review and meta-analysis. J Cancer Res Ther, 2016, 12(2): 543-549.
21. Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 2007, 447(7148): 1087-1093.
22. Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet, 2008, 4(4): e1000054.
23. 查国松, 左文述. BRCA1 与乳腺癌的研究进展. 中国普外基础与临床杂志, 2017, 24(7): 900-904.
24. Antoniou AC, Spurdle AB, Sinilnikova OM, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet, 2008, 82(4): 937-948.
25. 陈洁, 吕青, 王竹, 等. 乳腺癌分子病理学指标分布的异质性. 中国普外基础与临床杂志, 2016, 23(6): 761-766.